Literature DB >> 35092434

Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.

Stephen R Lowe1, Christopher P Wang2, Amanda Brisco2, Junmin Whiting3, John Arrington4, Kamran Ahmed5, Michael Yu5, Timothy Robinson5, Daniel Oliver5, Arnold Etame1, Nam Tran1, Andre Beer Furlan1, Solmaz Sahebjam1, Sepideh Mokhtari1, Yolanda Piña1, Robert Macaulay6, Peter Forsyth1, Michael A Vogelbaum1, James K C Liu1,2.   

Abstract

BACKGROUND: Leptomeningeal disease (LMD) is a devastating complication of systemic malignancy, of which there is an unclear etiology. The aim of this study is to determine if surgical or anatomic factors can predict LMD in patients with metastatic melanoma.
METHODS: A retrospective chart review was performed of 1162 patients treated at single institution for melanoma brain metastases (MBM). Patients with fewer than 3 months follow-up or lacking appropriate imaging were excluded. Demographic information, surgical, and anatomic data were collected.
RESULTS: Eight hundred and twenty-seven patients were included in the final review. On multivariate analysis for the entire cohort, female gender, dural-based and intraventricular metastasis, and tumor bordering CSF spaces were associated with increased risk of LMD. Surgical resection was not significant for risk of LMD. On multivariate analysis of patients who have undergone surgical resection of a metastatic tumor, dural-based and intraventricular metastasis, ventricular entry during surgery, and metastasis in the infratentorial space were associated with increased risk of LMD. On multivariate analysis of patients who did not undergo surgery, chemotherapy after initial diagnosis and metastasis bordering CSF spaces were associated with increased risk of LMD.
CONCLUSION: In a single-institution cohort of MBM, we found that surgical resection alone did not result in an increased risk of LMD. Anatomical factors such as dural-based and intraventricular metastasis were significant for developing LMD, as well as entry into a CSF space during surgical resection. These data suggest a strong correlation between anatomic location and tumor cell seeding in relation to the development of LMD.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  brain metastasis; leptomeningeal disease; melanoma; surgery

Mesh:

Year:  2022        PMID: 35092434      PMCID: PMC9340645          DOI: 10.1093/neuonc/noac023

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   13.029


  29 in total

1.  Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complication.

Authors:  L K Norris; S A Grossman; A Olivi
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

2.  Leptomeningeal metastases from small cell lung carcinoma.

Authors:  Tatjana Seute; Pieter Leffers; Guul P M ten Velde; Albert Twijnstra
Journal:  Cancer       Date:  2005-10-15       Impact factor: 6.860

Review 3.  Breast leptomeningeal disease: a review of current practices and updates on management.

Authors:  Nicholas B Figura; Victoria T Rizk; Avan J Armaghani; John A Arrington; Arnold B Etame; Hyo S Han; Brian J Czerniecki; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2019-06-17       Impact factor: 4.872

4.  Leptomeningeal metastasis after surgical resection of brain metastases.

Authors:  T C van der Ree; D W Dippel; C J Avezaat; P A Sillevis Smitt; C J Vecht; M J van den Bent
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

Review 5.  Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review.

Authors:  Roshan S Prabhu; Kirtesh R Patel; Robert H Press; Scott G Soltys; Paul D Brown; Minesh P Mehta; Anthony L Asher; Stuart H Burri
Journal:  Neurosurgery       Date:  2019-01-01       Impact factor: 4.654

6.  Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa.

Authors:  Dima Suki; Hiba Abouassi; Akash J Patel; Raymond Sawaya; Jeffrey S Weinberg; Morris D Groves
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

7.  Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis.

Authors:  Dima Suki; Mustafa Aziz Hatiboglu; Akash J Patel; Jeffrey S Weinberg; Morris D Groves; Anita Mahajan; Raymond Sawaya
Journal:  Neurosurgery       Date:  2009-04       Impact factor: 4.654

8.  Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.

Authors:  Andrew J Huang; Karen E Huang; Brandi R Page; Diandra N Ayala-Peacock; John T Lucas; Glenn J Lesser; Adrian W Laxton; Stephen B Tatter; Michael D Chan
Journal:  J Neurooncol       Date:  2014-07-22       Impact factor: 4.130

9.  Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.

Authors:  Anita Mahajan; Salmaan Ahmed; Mary Frances McAleer; Jeffrey S Weinberg; Jing Li; Paul Brown; Stephen Settle; Sujit S Prabhu; Frederick F Lang; Nicholas Levine; Susan McGovern; Erik Sulman; Ian E McCutcheon; Syed Azeem; Daniel Cahill; Claudio Tatsui; Amy B Heimberger; Sherise Ferguson; Amol Ghia; Franco Demonte; Shaan Raza; Nandita Guha-Thakurta; James Yang; Raymond Sawaya; Kenneth R Hess; Ganesh Rao
Journal:  Lancet Oncol       Date:  2017-07-04       Impact factor: 41.316

10.  Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis.

Authors:  Roshan S Prabhu; Brandon E Turner; Anthony L Asher; Samuel R Marcrom; John B Fiveash; Paul M Foreman; Robert H Press; Zachary S Buchwald; Walter J Curran; Kirtesh R Patel; William G Breen; Paul D Brown; Krishan R Jethwa; Inga S Grills; Jessica D Arden; Lauren M Foster; Matthew A Manning; Zachary K Vaslow; Stuart H Burri; Scott G Soltys
Journal:  Adv Radiat Oncol       Date:  2021-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.